Mad Money's Jim Cramer reflects on CNBC's evolution over the past 25 years.» Read More
Genentech today has essentially backed down from a proposed crackdown on doctors' use of the cancer drug Avastin instead of the way more expensive Lucentis. The drugs are used to treat age-related macular degeneration (AMD, for short), which is the leading cause of blindness in adults.
As we close out this year, I know some of you are asking, "Hey Toyota Phil (a nickname a friend gave me after accusing me of giving the Japanese automaker too much praise) what do you think will happen in the auto industry next year?" Well, since you asked, and I know some of you haven't asked, here are my prognostications for 2008.
This stodgy old company has a huge growth story.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
Most of my PR and professional contacts send Christmas cards, but for the past two years the boutique Wall Street firm, Rodman & Renshaw, has sent me heavy metal piggy banks. I assume the company sends them to its clients as well.
Bear Stearns's board is talking about a successor for Chief Executive Jimmy Cayne, CNBC has learned.
1st paragraph of story should go here
Eli Lilly announced this morning that Chairman and CEO Sidney Taurel is retiring as CEO on March 31st next year. He will stay on as Chairman and on April Fool's Day Chief Operating Officer John Lechleiter will take over as CEO. Investors, at least in early trading, seem to like the choice.
Sprint Nextel on Tuesday named former Embarq Corp Chief Executive Dan Hesse as its president and CEO, effective immediately.
Merry Christmas! The ECB's decision to inject half a trillion (trillion!) into the global marketplace (technically, they are providing what is essentially unlimited loans at a fixed fate for the next couple weeks) is definitely giving equities a shot in the arm this morning. This should put some pressure on bonds, lower LIBOR rates, and maybe prop up the dollar a bit.
Eli Lilly Tuesday said Sidney Taurel, the drugmaker's long-time chief executive officer, will retire on March 31 and will be succeeded by Chief Operating Officer John Lechleiter.
Thornburg Mortgage said Tuesday that it promoted its chief operating officer to CEO and reinstated a quarterly dividend despite ongoing turmoil in the mortgage market.
Novellus Systems, a supplier of equipment for making microchips, said Monday that its chief financial officer will resign around late February and join a private venture-backed company.
Student lender SLM -- better known as Sallie Mae -- said Friday that its executive chairman Albert Lord will take on the extra role of chief executive officer.
The biotech momentum players and the Dendreonites--or Dendreonians--are buzzing about the story we broke on "Power Lunch" Thursday that three members of Congress are asking the House Energy and Commerce Committee to hold a hearing about the Dendreon/Provenge saga. The shares spiked on very heavy volume.
Merrill Lynch ousted Chairman and Chief Executive Stan O'Neal just days after reporting the biggest quarterly loss in the company's history, making him the highest-ranking casualty in the U.S. subprime mortgage crisis.
Cramer says it's already priced into the stock.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
Novartis is the latest company to brand its downsizing, cost-cutting campaign. The Swiss drugmaker is calling its initiative, "Forward". It's not an acronym. So, "Forward" means Novartis is going to try to save $1.6 billion in 2010 and get rid of 2,500 employees. Although I don't think "Forward" is the word which begins with "f" that the affected workers would use to describe the initiative.
Goldman Sachs Chairman and Chief Executive Lloyd Blankfein is likely to get a 30 percent pay rise this year to about $70 million, despite the liquidity squeeze which has seen shares in the banking sector tumble, the Financial Times reported on its Web site.
Last year one of our producers had the bright idea of assigning each of CNBC's beat reporters a story about seven predictions for their beat for 2007. So, now this year not only do we have to do the 8 for '08 thing for TV, but also for the blog.
In the spirit of Outlook '08, here are my predictions for 2008. We'll see how I did come this time next year. My personal favorite is number 7!!